TY - JOUR AU - Pavel, M. AU - Baudin, E. AU - Couvelard, A. AU - Krenning, E. AU - Oberg, K. AU - Steinmuller, T. PY - 2012 DA - 2012// TI - ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary JO - Neuroendocrinology VL - 95 UR - https://doi.org/10.1159/000335597 DO - 10.1159/000335597 ID - Pavel2012 ER - TY - JOUR AU - Kwekkeboom, D. J. AU - Herder, W. W. AU - Kam, B. L. AU - Eijck, C. H. AU - Essen, M. AU - Kooij, P. P. PY - 2008 DA - 2008// TI - Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.15.2553 DO - 10.1200/JCO.2007.15.2553 ID - Kwekkeboom2008 ER - TY - JOUR AU - Bodei, L. AU - Cremonesi, M. AU - Grana, C. M. AU - Fazio, N. AU - Iodice, S. AU - Baio, S. M. PY - 2011 DA - 2011// TI - Peptide receptor radionuclide therapy with (1)(7)(7)Lu-DOTATATE: the IEO phase I-II study JO - Eur J Nucl Med Mol Imaging VL - 38 UR - https://doi.org/10.1007/s00259-011-1902-1 DO - 10.1007/s00259-011-1902-1 ID - Bodei2011 ER - TY - STD TI - Khan S, Krenning EP, van Essen M, Kam BL, Teunissen JJ, Kwekkeboom DJ. Quality of life in 265 patients with gastroenteropancreatic or bronchial neuroendocrine tumors treated with [177Lu-DOTA0, Tyr3]octreotate. J Nucl Med. 2011;52:1361–8. doi:10.2967/jnumed.111.087932jnumed.111.087932. ID - ref4 ER - TY - JOUR AU - Valkema, R. AU - Pauwels, S. A. AU - Kvols, L. K. AU - Kwekkeboom, D. J. AU - Jamar, F. AU - Jong, M. PY - 2005 DA - 2005// TI - Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate JO - J Nucl Med VL - 46 ID - Valkema2005 ER - TY - JOUR AU - Bodei, L. AU - Cremonesi, M. AU - Ferrari, M. AU - Pacifici, M. AU - Grana, C. M. AU - Bartolomei, M. PY - 2008 DA - 2008// TI - Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors JO - Eur J Nucl Med Mol Imaging VL - 35 UR - https://doi.org/10.1007/s00259-008-0778-1 DO - 10.1007/s00259-008-0778-1 ID - Bodei2008 ER - TY - JOUR AU - Sabet, A. AU - Ezziddin, K. AU - Pape, U. F. AU - Reichman, K. AU - Haslerud, T. AU - Ahmadzadehfar, H. PY - 2014 DA - 2014// TI - Accurate assessment of long-term nephrotoxicity after peptide receptor radionuclide therapy with (177)Lu-octreotate JO - Eur J Nucl Med Mol Imaging VL - 41 UR - https://doi.org/10.1007/s00259-013-2601-x DO - 10.1007/s00259-013-2601-x ID - Sabet2014 ER - TY - JOUR AU - Sabet, A. AU - Ezziddin, K. AU - Pape, U. F. AU - Ahmadzadehfar, H. AU - Mayer, K. AU - Poppel, T. PY - 2013 DA - 2013// TI - Long-term hematotoxicity after peptide receptor radionuclide therapy with 177Lu-octreotate JO - J Nucl Med VL - 54 UR - https://doi.org/10.2967/jnumed.112.119347 DO - 10.2967/jnumed.112.119347 ID - Sabet2013 ER - TY - JOUR AU - Bodei, L. AU - Kidd, M. AU - Paganelli, G. AU - Grana, C. M. AU - Drozdov, I. AU - Cremonesi, M. PY - 2015 DA - 2015// TI - Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors JO - Eur J Nucl Med Mol Imaging VL - 42 UR - https://doi.org/10.1007/s00259-014-2893-5 DO - 10.1007/s00259-014-2893-5 ID - Bodei2015 ER - TY - JOUR AU - Forrer, F. AU - Krenning, E. P. AU - Kooij, P. P. AU - Bernard, B. F. AU - Konijnenberg, M. AU - Bakker, W. H. PY - 2009 DA - 2009// TI - Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0), Tyr(3)]octreotate JO - Eur J Nucl Med Mol Imaging VL - 36 UR - https://doi.org/10.1007/s00259-009-1072-6 DO - 10.1007/s00259-009-1072-6 ID - Forrer2009 ER - TY - STD TI - Bergsma H, Konijnenberg MW, Kam BL, Teunissen JJ, Kooij PP, de Herder WW, et al. Subacute haematotoxicity after PRRT with Lu-DOTA-octreotate: prognostic factors, incidence and course. Eur J Nucl Med Mol Imaging. 2015. doi:10.1007/s00259-015-3193-4. ID - ref11 ER - TY - JOUR AU - Svensson, J. AU - Berg, G. AU - Wangberg, B. AU - Larsson, M. AU - Forssell-Aronsson, E. AU - Bernhardt, P. PY - 2015 DA - 2015// TI - Renal function affects absorbed dose to the kidneys and haematological toxicity during (1)(7)(7)Lu-DOTATATE treatment JO - Eur J Nucl Med Mol Imaging VL - 42 UR - https://doi.org/10.1007/s00259-015-3001-1 DO - 10.1007/s00259-015-3001-1 ID - Svensson2015 ER - TY - STD TI - Kaushansky K. Determinants of platelet number and regulation of thrombopoiesis. Hematology Am Soc Hematol Educ Program. 2009:147-52. doi:10.1182/asheducation-2009.1.147. ID - ref13 ER - TY - JOUR AU - Bakovic, D. AU - Eterovic, D. AU - Saratlija-Novakovic, Z. AU - Palada, I. AU - Valic, Z. AU - Bilopavlovic, N. PY - 2005 DA - 2005// TI - Effect of human splenic contraction on variation in circulating blood cell counts JO - Clin Exp Pharmacol Physiol VL - 32 UR - https://doi.org/10.1111/j.1440-1681.2005.04289.x DO - 10.1111/j.1440-1681.2005.04289.x ID - Bakovic2005 ER - TY - JOUR AU - Spencer, R. P. AU - Pearson, H. A. PY - 1975 DA - 1975// TI - The spleen as a hematological organ JO - Semin Nucl Med VL - 5 UR - https://doi.org/10.1016/S0001-2998(75)80007-9 DO - 10.1016/S0001-2998(75)80007-9 ID - Spencer1975 ER - TY - JOUR AU - Kwekkeboom, D. J. AU - Bakker, W. H. AU - Kooij, P. P. AU - Konijnenberg, M. W. AU - Srinivasan, A. AU - Erion, J. L. PY - 2001 DA - 2001// TI - [177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients JO - Eur J Nucl Med VL - 28 UR - https://doi.org/10.1007/s002590100574 DO - 10.1007/s002590100574 ID - Kwekkeboom2001 ER - TY - JOUR AU - Melis, M. AU - Kaemmerer, D. AU - Swart, J. AU - Kulkarni, H. R. AU - Lupp, A. AU - Sanger, J. PY - 2016 DA - 2016// TI - Localization of radiolabeled somatostatin analogs in the spleen JO - Clin Nucl Med VL - 41 UR - https://doi.org/10.1097/RLU.0000000000001026 DO - 10.1097/RLU.0000000000001026 ID - Melis2016 ER - TY - JOUR AU - Reubi, J. C. AU - Waser, B. AU - Horisberger, U. AU - Krenning, E. AU - Lamberts, S. W. AU - Gebbers, J. O. PY - 1993 DA - 1993// TI - In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue JO - Blood VL - 82 ID - Reubi1993 ER - TY - JOUR AU - Ferone, D. AU - Pivonello, R. AU - Kwekkeboom, D. J. AU - Gatto, F. AU - Ameri, P. AU - Colao, A. PY - 2012 DA - 2012// TI - Immunohistochemical localization and quantitative expression of somatostatin receptors in normal human spleen and thymus: Implications for the in vivo visualization during somatostatin receptor scintigraphy JO - J Endocrinol Invest VL - 35 UR - https://doi.org/10.1007/BF03345797 DO - 10.1007/BF03345797 ID - Ferone2012 ER - TY - JOUR AU - Ishibashi, N. AU - Maebayashi, T. AU - Aizawa, T. AU - Sakaguchi, M. AU - Abe, O. AU - Saito, T. PY - 2015 DA - 2015// TI - Myelosuppression toxicity of palliative splenic irradiation in myelofibrosis and malignant lymphoma JO - Hematology VL - 20 UR - https://doi.org/10.1179/1607845414Y.0000000192 DO - 10.1179/1607845414Y.0000000192 ID - Ishibashi2015 ER - TY - JOUR AU - Pistevou-Gombaki, K. AU - Zygogianni, A. AU - Kantzou, I. AU - Kyrgias, G. AU - Mystakidou, K. AU - Kouvaris, J. PY - 2015 DA - 2015// TI - Splenic irradiation as palliative treatment for symptomatic splenomegaly due to secondary myelofibrosis: a multi-institutional experience JO - J BUON VL - 20 ID - Pistevou-Gombaki2015 ER - TY - JOUR AU - Lavrenkov, K. AU - Krepel-Volsky, S. AU - Levi, I. AU - Ariad, S. PY - 2012 DA - 2012// TI - Low dose palliative radiotherapy for splenomegaly in hematologic disorders JO - Leuk Lymphoma VL - 53 UR - https://doi.org/10.3109/10428194.2011.614708 DO - 10.3109/10428194.2011.614708 ID - Lavrenkov2012 ER - TY - JOUR AU - Kriz, J. AU - Micke, O. AU - Bruns, F. AU - Haverkamp, U. AU - Mucke, R. AU - Schafer, U. PY - 2011 DA - 2011// TI - Radiotherapy of splenomegaly: a palliative treatment option for a benign phenomenon in malignant diseases JO - Strahlenther Onkol VL - 187 UR - https://doi.org/10.1007/s00066-011-2252-4 DO - 10.1007/s00066-011-2252-4 ID - Kriz2011 ER - TY - JOUR AU - Shrimali, R. K. AU - Correa, P. D. AU - O'Rourke, N. PY - 2008 DA - 2008// TI - Low-dose palliative splenic irradiation in haematolymphoid malignancy JO - J Med Imaging Radiat Oncol VL - 52 UR - https://doi.org/10.1111/j.1440-1673.2008.01958.x DO - 10.1111/j.1440-1673.2008.01958.x ID - Shrimali2008 ER - TY - JOUR AU - Magnander, T. AU - Wikberg, E. AU - Svensson, J. AU - Gjertsson, P. AU - Wangberg, B. AU - Bath, M. PY - 2016 DA - 2016// TI - A novel statistical analysis method to improve the detection of hepatic foci of (111)In-octreotide in SPECT/CT imaging JO - EJNMMI Physics VL - 3 UR - https://doi.org/10.1186/s40658-016-0137-4 DO - 10.1186/s40658-016-0137-4 ID - Magnander2016 ER - TY - STD TI - Eckerman Keith F EA. MIRD: radionuclide data and decay schemes. Reston: SNM Publication. 2008. ID - ref26 ER - TY - JOUR AU - Larsson, M. AU - Bernhardt, P. AU - Svensson, J. B. AU - Wangberg, B. AU - Ahlman, H. AU - Forssell-Aronsson, E. PY - 2012 DA - 2012// TI - Estimation of absorbed dose to the kidneys in patients after treatment with 177Lu-octreotate: comparison between methods based on planar scintigraphy JO - EJNMMI Res VL - 2 UR - https://doi.org/10.1186/2191-219X-2-49 DO - 10.1186/2191-219X-2-49 ID - Larsson2012 ER - TY - JOUR AU - Sandstrom, M. AU - Garske, U. AU - Granberg, D. AU - Sundin, A. AU - Lundqvist, H. PY - 2010 DA - 2010// TI - Individualized dosimetry in patients undergoing therapy with (177)Lu-DOTA-D-Phe (1)-Tyr (3)-octreotate JO - Eur J Nucl Med Mol Imaging VL - 37 UR - https://doi.org/10.1007/s00259-009-1216-8 DO - 10.1007/s00259-009-1216-8 ID - Sandstrom2010 ER - TY - JOUR AU - Kulkarni, H. R. AU - Prasad, V. AU - Schuchardt, C. AU - Baum, R. P. PY - 2013 DA - 2013// TI - Is there a correlation between peptide receptor radionuclide therapy-associated hematological toxicity and spleen dose? JO - Recent Results Cancer Res VL - 194 UR - https://doi.org/10.1007/978-3-642-27994-2_33 DO - 10.1007/978-3-642-27994-2_33 ID - Kulkarni2013 ER - TY - JOUR AU - Wang, X. AU - Prakash, S. AU - Lu, M. AU - Tripodi, J. AU - Ye, F. AU - Najfeld, V. PY - 2012 DA - 2012// TI - Spleens of myelofibrosis patients contain malignant hematopoietic stem cells JO - J Clin Invest VL - 122 UR - https://doi.org/10.1172/JCI64397 DO - 10.1172/JCI64397 ID - Wang2012 ER - TY - JOUR AU - Behr, T. M. AU - Memtsoudis, S. AU - Sharkey, R. M. AU - Blumenthal, R. D. AU - Dunn, R. M. AU - Gratz, S. PY - 1998 DA - 1998// TI - Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: influence of radiation dose and dose rate on toxicity and anti-tumor efficacy JO - Int J Cancer VL - 77 UR - https://doi.org/3.0.CO;2-Z DO - 3.0.CO;2-Z ID - Behr1998 ER - TY - JOUR AU - Fowler, J. F. PY - 1990 DA - 1990// TI - Radiobiological aspects of low dose rates in radioimmunotherapy JO - Int J Radiat Oncol Biol Phys VL - 18 UR - https://doi.org/10.1016/0360-3016(90)90467-X DO - 10.1016/0360-3016(90)90467-X ID - Fowler1990 ER - TY - BOOK AU - Betty, C. PY - 2012 DA - 2012// TI - Hematology in practice PB - F.A. Davis Company CY - Philadelphia, PA ID - Betty2012 ER -